Brief: Aeglea Bio Therapeutics To Transfer Listing From Nasdaq Global Market To Nasdaq Capital Market

Spyre Therapeutics

14/07/2023 21:25

July 14 (Reuters) - Aeglea Bio Therapeutics Inc
 AGLE.O :
    * AEGLEA BIO THERAPEUTICS INC - ON JUNE 30 APPLIED TO
TRANSFER
LISTING OF ITS COMMON STOCK FROM NASDAQ GLOBAL MARKET TO NASDAQ
CAPITAL MARKET
    * AEGLEA BIO THERAPEUTICS INC - ON JULY 13, RECEIVED
APPROVAL FROM
NASDAQ OF TRANSFER FROM NASDAQ GLOBAL MARKET TO NASDAQ CAPITAL
MARKET
    * AEGLEA BIO THERAPEUTICS INC - COMMON STOCK CONTINUES TO
TRADE
UNDER SYMBOL "AGLE."
    * AEGLEA BIO THERAPEUTICS-GRANTED ADDITIONAL 180-CALENDAR
DAY
GRACE PERIOD, OR UNTIL JAN 8, 2024 TO REGAIN COMPLIANCE WITH
MINIMUM BID PRICE REQUIREMENT

Further company coverage:  AGLE.O 

 ((Reuters.Briefs@thomsonreuters.com;))